Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:topotecan
|
| gptkbp:approvalYear |
1996
|
| gptkbp:ATCCode |
L01XX17
|
| gptkbp:CASNumber |
gptkb:123948-87-8
|
| gptkbp:form |
capsule
solution for infusion |
| https://www.w3.org/2000/01/rdf-schema#label |
Hycamtin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:mechanismOfAction |
topoisomerase inhibitor
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:anemia
nausea vomiting diarrhea neutropenia |
| gptkbp:status |
FDA approved
EMA approved |
| gptkbp:usedFor |
gptkb:cancer
Small Cell Lung Cancer |
| gptkbp:bfsParent |
gptkb:topotecan
|
| gptkbp:bfsLayer |
7
|